These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28978154)

  • 1. Novel
    Walker CJ; O'Hern MJ; Serna VA; Kurita T; Miranda MA; Sapp CE; Mutch DG; Cohn DE; Goodfellow PJ
    Oncotarget; 2017 Sep; 8(40):68758-68768. PubMed ID: 28978154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX17 is a tumor suppressor in endometrial cancer.
    Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
    Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX17 in cellular reprogramming and cancer.
    Tan DS; Holzner M; Weng M; Srivastava Y; Jauch R
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):65-73. PubMed ID: 31419525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in SOX17 are associated with congenital anomalies of the kidney and the urinary tract.
    Gimelli S; Caridi G; Beri S; McCracken K; Bocciardi R; Zordan P; Dagnino M; Fiorio P; Murer L; Benetti E; Zuffardi O; Giorda R; Wells JM; Gimelli G; Ghiggeri GM
    Hum Mutat; 2010 Dec; 31(12):1352-9. PubMed ID: 20960469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse.
    Engert S; Burtscher I; Liao WP; Dulev S; Schotta G; Lickert H
    Development; 2013 Aug; 140(15):3128-38. PubMed ID: 23824574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
    Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
    Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
    Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of recurrent FOXA2 mutations seen in endometrial cancers.
    Neff R; Rush CM; Smith B; Backes FJ; Cohn DE; Goodfellow PJ
    Int J Cancer; 2018 Dec; 143(11):2955-2961. PubMed ID: 30091462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role.
    Smith B; Neff R; Cohn DE; Backes FJ; Suarez AA; Mutch DG; Rush CM; Walker CJ; Goodfellow PJ
    Gynecol Oncol; 2016 Nov; 143(2):398-405. PubMed ID: 27538367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
    Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of human SOX17.
    Katoh M
    Int J Mol Med; 2002 Feb; 9(2):153-7. PubMed ID: 11786926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
    Schultheis AM; Martelotto LG; De Filippo MR; Piscuglio S; Ng CK; Hussein YR; Reis-Filho JS; Soslow RA; Weigelt B
    Int J Gynecol Pathol; 2016 Jul; 35(4):289-300. PubMed ID: 26556035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
    Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
    J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
    Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
    Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin.
    Abdel-Rahman WM; Kalinina J; Shoman S; Eissa S; Ollikainen M; Elomaa O; Eliseenkova AV; Bützow R; Mohammadi M; Peltomäki P
    Hum Mutat; 2008 Mar; 29(3):390-7. PubMed ID: 18165946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.